CAS 841301-32-4: Amenamevir
Formula:C24H26N4O5S
InChI:InChI=1S/C24H26N4O5S/c1-16-4-3-5-17(2)22(16)28(24(30)19-10-12-34(31,32)13-11-19)14-21(29)26-20-8-6-18(7-9-20)23-25-15-33-27-23/h3-9,15,19H,10-14H2,1-2H3,(H,26,29)
InChI key:InChIKey=MNHNIVNAFBSLLX-UHFFFAOYSA-N
SMILES:N(C(=O)C1CCS(=O)(=O)CC1)(CC(NC2=CC=C(C=C2)C=3N=CON3)=O)C4=C(C)C=CC=C4C
Synonyms:- N-(2-((4-(1,2,4-Oxadiazol-3-yl)phenyl)amino)-2-oxoethyl)-N-(2,6-dimethylphenyl)tetrahydro-2H-thiopyran-4-carboxamide 1,1-dioxide
- 2H-Thiopyran-4-carboxamide, N-(2,6-dimethylphenyl)tetrahydro-N-[2-[[4-(1,2,4-oxadiazol-3-yl)phenyl]amino]-2-oxoethyl]-, 1,1-dioxide
- Amenamevir
- N-(2,6-Dimethylphenyl)-N-(2-{[4-(1,2,4-oxadiazol-3-yl)phenyl] amino}-2-oxoethyl)-1,1-dioxothiane-4-carboxamide
- N-(2,6-Dimethylphenyl)tetrahydro-N-[2-[[4-(1,2,4-oxadiazol-3-yl)phenyl]amino]-2-oxoethyl]-2H-thiopyran-4-carboxamide 1,1-dioxide
- ASP 2151
- Amenamevir(ASP 2151)
- ASP-2151
Sort by
Found 7 products.
Amenamevir
CAS:Amenamevir (ASP2151) is a novel helicase-primase inhibitor that is active against varicella-zoster virus and herpes simplex virus types 1 and 2 (EC50: 14 ng/mLFormula:C24H26N4O5SPurity:99.00% - 99.86%Color and Shape:SolidMolecular weight:482.55Ref: TM-T4226
1mg60.00€2mg79.00€5mg124.00€10mg197.00€25mg325.00€50mg505.00€100mg730.00€500mg1,501.00€1mL*10mM (DMSO)140.00€Amenamevir
CAS:Amenamevir is an antiviral medication, which is synthesized from a chemical source. Its mode of action involves the selective inhibition of the helicase-primase complex of the varicella-zoster virus (VZV), thereby disrupting the viral DNA replication process. By specifically targeting this enzyme complex, Amenamevir impairs the viral replication machinery, leading to a reduction in viral load and amelioration of symptoms associated with infection. This compound is particularly used in the treatment of herpes zoster infections, also known as shingles, in immunocompetent patients. Amenamevir offers a targeted approach to controlling the reactivation of the VZV, thus minimizing the intensity and duration of acute viral episodes. The use of Amenamevir is a significant advancement in antiviral therapy as it provides an alternative mechanism of action compared to traditional nucleoside analogs, thereby expanding the arsenal available for viral inhibition and management in clinical settings.Formula:C24H26N4O5SPurity:Min. 95%Molecular weight:482.55 g/mol
